Development of (177)Lu-phytate Complex for Radiosynovectomy.

Iran J Basic Med Sci

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran, P.O.Box:14395-836 ; Faculty of Energy Engineering and Physics, Amirkabir University of Technology. Tehran, Iran.

Published: May 2013

Objective(s): In this work a new possible agent for radiosynovectomy has been targeted for articular pain palliation.

Materials And Methods: Lu-177 of 2.6-3 GBq/mg specific activity was obtained by irradiation of natural Lu2O3 sample with thermal neutron flux of 4 × 10(13) n.cm(-2).s(-1). The product was converted into chloride form which was further used for labeling of (177)Lu-phytate complex and checked using ITLC (MeOH: H2O: acetic acid, 4: 4: 2, as mobile phase). The complex stability and viscosity were checked in the final solution up to seven days. The prepared complex solution (100 µCi/100 µl) was injected intra-articularly to male rat knee joint. Leakage of radioactivity from injection site and its distribution in organs were investigated up to seven days.

Results: The complex was successfully prepared with high radiochemical purity (>99.9 %). Approximately, the whole injected dose has remained in injection site seven days after injection.

Conclusion: The complex was proved to be a feasible agent for cavital radiotherapy in oncology and rheumatology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700046PMC

Publication Analysis

Top Keywords

177lu-phytate complex
8
injection site
8
complex
6
development 177lu-phytate
4
complex radiosynovectomy
4
radiosynovectomy objectives
4
objectives work
4
work agent
4
agent radiosynovectomy
4
radiosynovectomy targeted
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!